Global Fund

WHA, together with our partners, has been advocating for the Global Fund, one of the largest global health funders, to actively explore ways in which hepatitis elimination programmes can be integrated with existing HIV/AIDS, tuberculosis and malaria programmes. We believe that with their support the elimination of viral hepatitis can be accelerated. 

The advocacy began before the Global Fund replenishment meeting when 1,000 organisations and people signed our open letter to them which you can read here

As part of this advocacy we also worked with partners to convene a meeting during the Global Fund's 2019 replinshment meeting in Lyon, France. The World Health Organization compliled a report from the event which can be seen here.

https://www.who.int/publications-detail/financing-prevention-testing-and-treatment-of-hepatitis-gfatm-satellite-report 

Co-infection 

In 2020 Global Fund country recipients are preparing their concept notes for the next round of funding. Current Global Fund policy enables countries to apply for support for work with HIV/AIDs and hepatitis C co-infection. Currently, few countries are utilising this support. WHA members have a key role to play in ensuring countries take up this support. We have prepared an advocacy briefing that can be used by members in countries that receive Global Fund support to help them advocate for the inclusion of co-infection support in the country concept notes.